Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients

  • Takashi Takeshita1,
  • Yutaka Yamamoto1,
  • Mutsuko Yamamoto-Ibusuki2,
  • Aiko Sueta1,
  • Mai Tomiguchi1,
  • Keiichi Murakami1,
  • Yoko Omoto1, 3 and
  • Hirotaka Iwase1Email author
BMC Cancer201717:786

https://doi.org/10.1186/s12885-017-3779-2

Received: 31 July 2016

Accepted: 13 November 2017

Published: 22 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Jul 2016 Submitted Original manuscript
4 Apr 2017 Reviewed Reviewer Report - Agnes Jager
19 Jun 2017 Author responded Author comments - Takashi Takeshita
Resubmission - Version 2
19 Jun 2017 Submitted Manuscript version 2
5 Oct 2017 Author responded Author comments - Takashi Takeshita
Resubmission - Version 3
5 Oct 2017 Submitted Manuscript version 3
29 Oct 2017 Author responded Author comments - Takashi Takeshita
Resubmission - Version 4
29 Oct 2017 Submitted Manuscript version 4
Publishing
13 Nov 2017 Editorially accepted
22 Nov 2017 Article published 10.1186/s12885-017-3779-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University
(2)
Department of Molecular-Targeting Therapy for Breast Cancer, Kumamoto University Hospital
(3)
Department of Endocrinological and Breast Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Advertisement